TY - JOUR
T1 - A 360-degree overview of paediatric NAFLD: Recent insights
AU - Nobili, Valerio
AU - Svegliati-Baroni, Gianluca
AU - Alisi, Anna
AU - Miele, Luca
AU - Valenti, Luca
AU - Vajro, Pietro
PY - 2013
Y1 - 2013
N2 - Non-alcoholic fatty liver disease (NAFLD) is a multi-faceted disorder, which ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) with/without fibrosis. The effects of specific risk factors, such as obesity and sedentary lifestyle, on predisposing genetic settings eventually lead to the development of NAFLD in children. The complex interplay between genes and environment in NAFLD pathogenesis is sustained by multiple mechanisms that involve liver crosstalk with other organs and tissues, especially gut and adipose tissue. Unfortunately, natural history of paediatric NAFLD is lacking, and the etiopathogenesis is still in the process of being defined. Potential early predictors and suitable non-invasive diagnostic tools can be discovered based on the pathogenetic mechanisms and histological patterns. This will also help design novel treatments and a comprehensive and successful management strategy for patients. In this review, we discuss the recent advances made in genetics, etiopathogenesis, diagnosis, and therapeutic management of NAFLD, focusing especially on the obesity-related steatotic liver condition. © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
AB - Non-alcoholic fatty liver disease (NAFLD) is a multi-faceted disorder, which ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) with/without fibrosis. The effects of specific risk factors, such as obesity and sedentary lifestyle, on predisposing genetic settings eventually lead to the development of NAFLD in children. The complex interplay between genes and environment in NAFLD pathogenesis is sustained by multiple mechanisms that involve liver crosstalk with other organs and tissues, especially gut and adipose tissue. Unfortunately, natural history of paediatric NAFLD is lacking, and the etiopathogenesis is still in the process of being defined. Potential early predictors and suitable non-invasive diagnostic tools can be discovered based on the pathogenetic mechanisms and histological patterns. This will also help design novel treatments and a comprehensive and successful management strategy for patients. In this review, we discuss the recent advances made in genetics, etiopathogenesis, diagnosis, and therapeutic management of NAFLD, focusing especially on the obesity-related steatotic liver condition. © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
KW - Children
KW - Fibrosis
KW - NAFLD
KW - NASH
KW - Children
KW - Fibrosis
KW - NAFLD
KW - NASH
UR - http://hdl.handle.net/10807/219670
U2 - 10.1016/j.jhep.2012.12.003
DO - 10.1016/j.jhep.2012.12.003
M3 - Article
SN - 0168-8278
VL - 58
SP - 1218
EP - 1229
JO - Journal of Hepatology
JF - Journal of Hepatology
ER -